HER2 Support Group Forums - View Single Post

MJo · 10-20-2006, 10:00 AM

Susan. I hope you will get a second opinion.
I had a .55 CM tumor, no nodes, er/pr+ and Her2++. That made me stage T1B, very early. I had the Oncotype DX test, which has been shown to accurately predict recurrence rates for node-neg women who are trying to decide whether to take chemo. My score was 32, the beginning of the high risk category, with a 22.5% chance of recurrence in 10 years. I recently visited the Johns Hopkins Ask an Expert site. Their position is that the Oncotype DX test is useful for node-neg women who ARE NOT HER2+. I'll bet you that EVERY Her2 tumor tested by Oncotype this past year has been high risk. I am glad I could add to the body of knowledge. It cost me $3000, since insurance wouldn't pay for the test.

Please consider getting taxol, which has been shown to increase the efficacy of Herceptin. I think we need to treat Her2 aggressively.

10-20-2006, 10:00 AM	#10
MJo Senior Member Join Date: Apr 2006 Location: Wilmington, Del. Posts: 1,126	Susan. I hope you will get a second opinion. I had a .55 CM tumor, no nodes, er/pr+ and Her2++. That made me stage T1B, very early. I had the Oncotype DX test, which has been shown to accurately predict recurrence rates for node-neg women who are trying to decide whether to take chemo. My score was 32, the beginning of the high risk category, with a 22.5% chance of recurrence in 10 years. I recently visited the Johns Hopkins Ask an Expert site. Their position is that the Oncotype DX test is useful for node-neg women who ARE NOT HER2+. I'll bet you that EVERY Her2 tumor tested by Oncotype this past year has been high risk. I am glad I could add to the body of knowledge. It cost me $3000, since insurance wouldn't pay for the test. Please consider getting taxol, which has been shown to increase the efficacy of Herceptin. I think we need to treat Her2 aggressively.